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Abstract
Background: Although type I interferons (IFNs)—key effectors of antiviral innate immunity are known to be induced
via different pattern recognition receptors (PRRs), the cellular source and the relative contribution of different PRRs in
host protection against viral infection is often unclear. IPS-1 is a downstream adaptor for retinoid-inducible gene
I (RIG-I)-like receptor signaling. In this study, we investigate the relative contribution of IPS-1 in the innate immune
response in the different brain regions during infection with tick-borne encephalitis virus (TBEV), a flavivirus that causes
a variety of severe symptoms like hemorrhagic fevers, encephalitis, and meningitis in the human host.
Methods: IPS-1 knockout mice were infected with TBEV/Langat virus (LGTV), and viral burden in the peripheral and the
central nervous systems, type I IFN induction, brain infiltrating cells, and inflammatory response was analyzed.
Results: We show that IPS-1 is indispensable for controlling TBEV and LGTV infections in the peripheral and central
nervous system. Our data indicate that IPS-1 regulates neuropathogenicity in mice. IFN response is differentially
regulated in distinct regions of the central nervous system (CNS) influencing viral tropism, as LGTV replication was
mainly restricted to olfactory bulb in wild-type (WT) mice. In contrast to the other brain regions, IFN upregulation in the
olfactory bulb was dependent on IPS-1 signaling. IPS-1 regulates basal levels of antiviral interferon-stimulated genes
(ISGs) like viperin and IRF-1 which contributes to the establishment of early viral replication which inhibits STAT1
activation. This diminishes the antiviral response even in the presence of high IFN-β levels. Consequently, the absence
of IPS-1 causes uncontrolled virus replication, in turn resulting in apoptosis, activation of microglia and astrocytes,
elevated proinflammatory response, and recruitment of inflammatory cells into the CNS.
Conclusions: We show that LGTV replication is restricted to the olfactory bulb and that IPS-1 is a very important player
in the olfactory bulb in shaping the innate immune response by inhibiting early viral replication and viral spread
throughout the central nervous system. In the absence of IPS-1, higher viral replication leads to the evasion of antiviral
response by inhibiting interferon signaling. Our data suggest that the local microenvironment of distinct brain regions
is critical to determine virus permissiveness.
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Background
The type I interferon system is the first line of defense
against virus infections [1–5]. During viral replication,
RNA intermediates are generated and recognized by dis-
tinct host pattern recognition receptors (PRRs). Two
classes of PRRs, endosomal toll-like receptors (TLR) and
cytoplasmic retinoid-inducible gene I (RIG-I)-like recep-
tors (RLRs), are essential for the detection and protec-
tion against viral infection. However, the specific PRRs
involved in mediating antiviral response are likely to be
virus and cell type-specific [6–8]. Endosomal TLR3 and
TLR7 recognize viral double-stranded RNA (dsRNA)
and single-stranded DNA (ssRNA) and signal through
their adaptor proteins TRIF (TLR3) and Myd88 (TLR7)
to induce type I interferons (IFNs) via transcription fac-
tors IRF3 and IRF7, respectively [9]. RLRs such as RIG-I
and melanoma differentiation antigen 5 (MDA5) are
double stranded RNA binding DExD/H box RNA heli-
cases [10, 11]. After the recognition of viral RNA, they
interact with mitochondrial associated adaptor protein
interferon -β promoter stimulator 1 (IPS-1; also known
as MAVS, VISA, or CARDIF) [12–15]. This interaction
leads to downstream signaling and activation of tran-
scription factors IRF3 and NF-κB, which translocate to
the nucleus and activate type I IFN and proinflammatory
genes [16, 17].
Type I IFNs are locally produced in the central ner-
vous system (CNS) upon viral infection. The producing
cell types differ from parenchymal cells upon influenza
and La Crosse virus to astrocytes upon vesicular stoma-
titis virus (VSV) infection [18–20]. However, very little is
known about the importance and the relative contribu-
tion of the different PRRs in the different regions of the
CNS for protection against neurotropic viruses.
Tick-borne encephalitis virus (TBEV) is one of the
emerging arthropod-borne viral (arboviral) diseases in
Europe and Asia. It is a neurotropic-enveloped RNA
virus of the Flaviviridae family and closely related to
other human pathogens such as yellow fever virus, den-
gue virus, West Nile virus (WNV), Japanese encephalitis
virus (JEV), and Murray Valley encephalitis virus [21].
The virus is transmitted via tick bites or consumption of
infected milk [22, 23]. The infection is characterized by
a biphasic course in the primary phase, patients show
signs of fatigue, headache, pain, and fever, followed by a
second phase of neurological involvement with symp-
toms of encephalitis, meningitis, and paralysis. The mor-
tality rate ranges from 0.5 to 30 %, with 30 to 60 % of
survivors developing neurological sequelae [24–27]. Al-
though an effective vaccine is available, treatment op-
tions are limited to supportive care [28]. Given such
high medical importance along with the increasing num-
ber of cases, and expansion into new unaffected areas,
many aspects of TBEV pathogenesis and immunity are
still unclear. Langat virus (LGTV) is a naturally attenu-
ated member of TBEV serogroup [29]. LGTV shares
close molecular relationship (82–88 % amino acid iden-
tity) with TBEV and thus make it an ideal surrogate
model to study TBEV pathogenesis [24].
We have recently shown that type I IFNs protect and
control TBEV- and LGTV-induced inflammation and
encephalitis by limiting systemic LGTV replication,
spreading to CNS and the associated immunopathology
[30]. However, the cell types and specific PRRs involved
in IFN induction and clearance of LGTV are not known.
In the current study, we have determined the relative
contribution of IPS-1 signaling in LGTV disease devel-
opment and protection. We show that the tropism of
the virus in the CNS is shaped by the IFN response, and
that IPS-1 signaling is very important for IFN-β upregu-
lation in the olfactory bulb. The absence of IPS-1 leads
to uncontrolled viral replication in CNS but plays only a




All animal experiments were performed in compliance
with the German animal welfare law (TierSchG BGBl. S.
1105; 25.05.1998). The mice were housed and handled
in accordance with good animal practice as defined by
FELASA. All animal experiments were approved by the
responsible state office (Lower Saxony State Office of
Consumer Protection and Food Safety) under permit
number AZ 33.9-42502-04-11/0528.
Mice and viral infections
C57BL/6 wild-type (WT) mice were purchased from
Harlan. IPS-1−/− mice on the C57BL/6 background were
bred under specific pathogen free conditions at the
Helmholtz Centre for Infection Research. LGTV strain
TP21 and TBEV strain Hypr71 (G. Dobler) were propa-
gated in Vero B4 cells. Titers were determined by focus
forming assays on Vero B4 cells [31]. Six- to ten-week-
old mice were intraperitoneally infected with the indi-
cated focus forming units (FFU) of LGTV or TBEV in
100-μl phosphate buffered saline (PBS). For intracranial
infections, mice were anesthetized by intraperitoneal in-
jection with a mixture of ketamine (100 μg/g body
weight) and xylazine (5 μg/g body weight). Mice were
injected with indicated FFU of LGTV in 20 μl PBS. Mice
that lost more than 20 % of their body weight were
sacrificed and perfused with 10 ml of PBS. Experiments
with TBEV strain Hypr were performed in the biosafety
level 3 (BSL3) facility at the Helmholtz Center for Infec-
tion Research.
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Focus forming assay
Viral titers were determined by using a focus forming
assay as described previously [31]. Briefly, serial dilution
of virus samples were added on monolayer of Vero B4
cells in 96-well plates. After 1 h of incubation at 37 °C
in a 5 % CO2, inoculum was removed and overlaid with
1.2 % Avicel RC-591 NF (FMC Biopolymer), 1× DMEM.
Cell monolayers were fixed with 6 % paraformaldehyde
dissolved in phosphate-buffered saline (PBS) 48 h post
infection and permeabilized with 0.5 % triton X 100 and
20 mM glycine in PBS. LGTV foci were stained with
monoclonal TBEV E antibody (monoclonal antiserum
1786 [32]) diluted 1:1000 in PBS supplemented with
10 % fetal calf serum (FCS) and 0.05 % tween 80 and
horse reddish peroxidase-conjugated anti-mouse im-
munoglobulin (Thermo Scientific) diluted 1:2000 in PBS,
10 % FCS and 0.05 % tween 80. Antibody-bound infec-
tion foci were visualized with True BlueTM Peroxidase
substrate (KPL Inc., Maryland, USA), counted under
microscope, and virus titer was expressed as focus form-
ing unit per milliliter (FFU/ml).
RNA extraction and real-time RT-PCR
RNA extraction from serum was done with QIAamp
Viral RNA mini kit (QIAGEN), and LGTV levels were
determine by comparing with a standard curve. The
standard curve for viral RNA in serum was generated by
RNA extraction, complementary DNA (cDNA) synthesis,
and quantification with real-time reverse transcription
PCR (RT-PCR) of control serum spiked with 1 – 105 FFU
of LGTV. Mice organs were homogenized in Trizol re-
agent (Invitrogen) using Lysis Matrix (Nordic Biolabs) and
the tissue homogenizer Fast Prep-24 (MP). The RNA was
extracted using the Nucleo-Spin RNA II kit (Macherey
Nagel). Five hundred nanograms of total RNA was used to
synthesize cDNA with the QuantiTect Reverse Transcrip-
tion Kit (Qiagen). Expression levels of mouse GAPDH,
IFN-β, IFN-α4, IFN-λ, Mx1, viperin, IL6, CCL5, CXCL10,
IRF1, and TRIM79α were detected by validated Quanti-
Tect primer assays (Qiagen) and the KAPA SYBR FAST
quantitative polymerase chain reaction (qPCR) Kit using
the 7900HT Fast-Real-time PCR System (Applied Bio-
systems). Viral RNAs were detected by two different
TaqMan-based assays; the TaqMan probe for TBEV
[33] detecting the 3′ NCR with a sensitivity of 104 copies
for LGTV or the newly developed LGTV NS3-based Taq-
Man assay, forward primer 5′-AACGGAGCCATAGC
CAGTGA-3′, reverse primer 5′-AACCCGTCCCGCCAC
TC-3′ and probe FAM-AGAGACAGATCCCTGATGG-
MGB, with a sensitivity of 10 copies. For both assays, the
KAPA probe FAST qPCR kit was used. Signals of indicated
messenger RNA (mRNA) or viral RNAs were normalized
to the GAPDH mRNA signal.
Brain immune cell quantification
Mice brains were harvested from uninfected or LGTV-
infected mice. Following perfusion, brains were homoge-
nized through a 70-μm cell strainer, digested with a
collagenase solution (500 μg/ml collagenase D, 0.1 μg/ml
trypsin inhibitor TLCK, 10 μg/ml DNase I, 10 mM
HEPES in HBSS) for 1 h at room temperature. Cells
were separated by centrifugation on a discontinuous 70-
to-30 % Percoll gradient. For the detection of resident
microglia, infiltrating macrophages and dendritic cells
were incubated with anti-CD45, anti-CD11b, and anti-
CD11c antibodies (BD Biosciences). Infiltrating T cells
were detected using anti-CD3, anti-CD4, and anti-CD8
antibodies (BD Biosciences). Brain leukocyte numbers
were quantitated using TruCount beads (BD Biosci-
ences). Analysis was performed on BD LSRII using BD
FACSDiva and FlowJo software.
Immunhistology
Immunohistological analysis were performed from WT
and IPS-1−/− mice infected with LGTV at different time
points (n = 3 per time point). Brains were removed after
cardiac perfusion with PBS followed by 4 % paraformal-
dehyde (PFA) and incubated 24 h in 4 % PFA followed
by an incubation in 30 % sucrose in 0.1 M phosphate
buffer for an additional 24 h. Subsequently, the brains
were frozen in Tissue Tek® Compound at -80 °C. 30 μm
sagittal slices of the whole brain were cut using a freez-
ing microtome (Frigomobil, Leica, Germany). All stain-
ing procedures were performed on free floating sections.
Following a 1-h blocking step at room temperature in
PBS containing 1 % BSA, 0.2 % Triton, and 10 % goat
serum, the slices were incubated overnight at 4 °C in pri-
mary antibody solution consisting of 10 % goat serum
and 0.2 % Triton in PBS. The following antibodies were
used: monoclonal TBEV E antibody (monoclonal anti-
serum 1786 [32]) monoclonal mouse anti-GFAP (Sigma,
1:500), monoclonal guinea pig anti-NeuN (SySY, 1:500),
polyclonal rabbit anti-IBA1 (Synaptic System, 1:500),
and polyclonal rabbit anti- cleaved caspase 3 [Asp175]
(Cell Signaling, 1:400). Secondary anti-mouse, anti-
guinea pig, or anti-rabbit antibodies conjugated with
FITC, Cy3, or Cy5 (Jackson ImmunoResearch) were in-
cubated 1:500 in PBS for 2 h at room temperature. All
analyzed samples were comparable and support the con-
clusion. Representative pictures are shown.
Primary cell isolation and infection
Primary mouse hippocampal neurons were generated
from WT and IPS-1−/− mouse embryos E18 as described
previously [34]. Briefly, 70,000 dissociated hippocampal
cells were seeded on poly-L-lysine coated cover slips and
incubated in Neurobasal medium (Invitrogen) supple-
mented with 2 % B27 (Invitrogen), 1× N-2 supplement
Kurhade et al. Journal of Neuroinflammation  (2016) 13:22 Page 3 of 14
(Invitrogen) and 0.5 mM Glutamax at 37 °C, 5 % CO2,
and 95 % humidity. After 2 weeks, cells were infected
with LGTV (MOI-0.001) and kinetics of viral replication
was recorded by focus forming assay.
Western blot analysis
For preparation of extracts, the brains or brain parts
were lysed in buffer containing 250 mmol/L Tris, 0.5 %
Triton X-100, and Halt protease inhibitor cocktail
(Thermo Scientific, Schwerte, Germany). Western blot
analysis was performed according to standard proce-
dures. The following primary antibodies were used:
Anti-STAT1-P (Tyr701, 58D6; Cell Signaling, Frankfurt,
Germany), anti-STAT1 (STAT91/84; Transduction La-
boratories Lexington, USA), and anti-actin (MAB 1501R,
Chemicon, Limburg, Germany). Horseradish-peroxidase-
conjugated anti-rabbit and anti-mouse antibodies
(Amersham, Freiburg, Germany) were used as secondary
antibodies using enhanced chemoluminescence detec-
tion (Bio-Rad, München, Germany). The chemilumines-
cence signal was recorded digitally by a ChemiDoc DRS
imaging system (Bio-Rad, München, Germany). Digital
signal acquisition and analysis were performed using the
Quantity One Program (version 4.6; Bio-Rad, München,
Germany).
Results
IPS-1-mediated type I IFN response controls LGTV
replication in the CNS but has minor role in peripheral
organs
Previously, we showed that type I IFN response in both
the peripheral and the central nervous system is indis-
pensable for the control of LGTV and TBEV infection
[30]. Here we were interested in understanding the PRR
pathways responsible for antiviral innate immunity. To
investigate the role of RIG-I-like receptors and wild-type
(WT) and IPS-1−/− mice were infected intraperitoneally
with 104 focus forming units (FFU) of LGTV or TBEV
strain Hypr (Fig. 1a, b). IPS-1−/− mice were found to be
highly susceptible to LGTV infection, with a 100 % mor-
tality rate, compared to WT mice that displayed only
20 % mortality (Fig. 1a). IPS-1−/− mice started showing
symptoms of paralysis, lethargy, hunchback posture, fur
ruffling, and weight loss 2 days before death, with a me-
dian survival time of 9 days. IPS-1−/− mice infected with
highly pathogenic TBEV strain Hypr also showed 100 %
mortality but died earlier with a median survival time of
Fig. 1 IPS-1 signaling controls LGTV replication in the CNS. a, b Survival of WT and IPS-1−/− mice. Mice were inoculated with 104 FFU of LGTV (WT
n = 10, IPS-1−/− n = 10) or TBEV strain Hypr 71 (WT n = 10, IPS-1−/− n = 5) via the intraperitoneal route and monitored for mortality for 21 days.
Survival differences were tested for statistical significance by the log-rank test. c Viral burden in serum (n = 5). Serum were harvested various days
post intraperitoneal infection of LGTV (104 FFU). Viral RNA in the serum was quantified by real-time RT-PCR detecting the LGTV NS3 and compared
with a standard curve derived from control serum samples spiked with LGTV. Number sign means not detectable; dotted line represents the detection
limit. d–g Viral burden in different organs after intraperitoneal infection of LGTV (104 FFU, n = 5–6) measured by real-time qPCR detecting LGTV NS3
gene (detection limit 10 copies) and normalized to intracellular GAPDH levels. d Spleen. e Lung. f Spinal cord. g Brain. Asterisks indicate
statistical significance calculated by Mann-Whitney test, **p < 0.01, *p < 0.05. au arbitrary units
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6 days post infection (dpi) (Fig. 1b). This was in contrast
to WT mice that exhibited longer survival; 90 % of WT
mice died in a median time of 9 dpi, with encephalitic
symptoms (p < 0.005). IFNAR−/− mice, on the other
hand, were more susceptible and succumbed within
5 dpi [30]. These data show that while IPS-1 signaling is
essential for defense against LGTV and TBEV infection,
other pattern recognition receptors also play an import-
ant role in protection against LGTV and TBEV
infections.
We evaluated the viral burden in the serum, peripheral
organs, and the CNS of LGTV-infected WT and IPS-1
−/− mice. Quantitative real time RT-PCR analysis of viral
RNA detected higher LGTV levels in serum and only
low levels of LGTV in peripheral organs of IPS-1−/− but
not in WT mice (Fig. 1c–e), indicating that higher
viremia in serum of IPS-1−/− mice results in higher viral
load entering the brain. The most important LGTV was
readily detected 4 dpi in the brain in both WT and IPS-1
mice, indicating that LGTV has a strong tropism of the
brain (Fig. 1f–g).
Consistent with the importance of IPS-1 in type I IFN
induction, ELISA analysis of serum from LGTV-infected
mice revealed lower IFN-α levels in IPS-1−/− mice
(Additional file 1: Figure S1). These results indicate that
IPS-1 mediated IFN response control systemic viral rep-
lication and higher viral replication in the circulation
leads to a higher viral load in the brain. More import-
antly, IPS-1 is vital for controlling LGTV replication
within the CNS.
Enhanced inflammation and immune cell infiltration in
the CNS of LGTV-infected IPS-1−/− mice
Given the uncontrolled LGTV replication in CNS of
IPS-1−/− mice and the fact that such mice displayed en-
cephalitic symptoms, next, we sought to understand
how IPS-1 ablation influences virus-induced inflamma-
tion in the brain. RT-PCR analysis of brains 4 and 7 days
post intraperitoneal LGTV infection revealed enhanced
induction of IFN-β 4 dpi while no statistical difference
in IFN-α4 and IFN-λ were observed (Fig. 2a–c). Mx-1
and viperin are key interferon inducible antiviral effec-
tors. Curiously, in spite of a higher IFN-β response in
IPS-1−/− mice, due to a higher viral titer in such mice
(Fig. 1g), no difference between WT and IPS-1−/− was
detected in the induction of Mx-1 and viperin
(Fig. 2d, e). Importantly, activation of genes for pro-
inflammatory cytokines such as IL-6 as well as those
for various chemokines including CCL5 7 dpi and
CXCL10 4 dpi was found to be significantly higher
Fig. 2 Impact of IPS signaling on chemokine, cytokine, and ISG expression upon virus infection. WT and IPS-1−/− mice were infected intraperitoneally
with 104 FFU of LGTV, and the brains were harvested on 0, 4, and 7 dpi. Expression levels of IFN-β, IFN-α4, IFN-λ, Mx1, viperin, IL6, CCL5, and CXCL10
were determined by real-time RT-PCR (a–h). Data represent the mean and standard error of the mean (SEM) of five to six mice per time point from at
least two independent experiments. Asterisks indicates statistical significance calculated by Mann-Whitney test, **p < 0.01
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in brains of IPS-1−/− mice (Fig. 2f–h). Thus, in the
absence of IPS-1 signaling, LGTV infection induces
a higher inflammatory response in the brain and a
delayed interferon-stimulated gene (ISG) induction.
Next, we employed flow cytometry to evaluate the
effect of IPS-1 deficiency on the recruitment of inflam-
matory cells into the brain. IPS-1−/− mice exhibited
brain-infiltration by different immune cells types includ-
ing macrophages, neutrophils (CD45hiCD11b+), DC
(CD11c+), and T cells (CD4+ and CD8+) (Fig. 3a–e). The
immune cell infiltration was detectable 7 dpi and was as-
sociated with leakage of the blood brain barrier, as
revealed by Evans blue injection (Additional file 2: Figure
S2) and not at earlier time points such as 4 dpi. Notably,
a slight increase in the DC population was however
observed on 4 dpi in brains of IPS-1−/− mice when the
BBB was intact (Fig. 3d). This observation could be due
to differentiation of microglia into brain resident DCs as
a result of production of proinflammatory cytokines
[35]. This is in contrast to brain-resident microglia
(CD45lowCD11b+) that remained unchanged on 7 dpi
(Fig. 3f ). Direct killing of the neurons by apoptosis has
been reported for both LGTV and TBEV in cell culture
[36, 37], and apoptosis in the brain might influence the
susceptibility of the mice to LGTV infection. We there-
fore set out to investigate the levels of apoptosis in WT
and IPS-1−/− brains after LGTV infection. We employed
immunohistochemistry to determine the extent of apop-
tosis by analyzing cleaved caspase 3 (Asp175) levels in
LGTV-infected WT and IPS-1−/− mice brain. High level
Fig. 3 Increased CNS infiltration in the absence of IPS-1 signaling. WT and IPS-1−/− mice were infected intraperitoneally with 104 FFU of LGTV.
Leukocytes were isolated from the brains at different time points 0, 4, and 7 dpi by Percoll gradient centrifugation, stained for various cell markers,
and analyzed by flow cytometry. a The total number of brain lymphocytes was determined by cell counting. b The total number of CD4+ T cells.
c The total number of CD8+cells. d The total number of dendritic (CD11c+) cells. e The total number of infiltrating macrophages and neutrophils
(CD45hiCD11b+). f The total number of microglia (CD45lowCD11b+). g Representative flow cytometry diagram of CD45 and CD11b staining of
brain leukocytes from WT and IPS-1−/− mice. Data represent the mean and standard error of the mean (SEM) of 3–10 mice per time point from at
least two independent experiments. h WT and IPS-1−/− mice were infected intraperitoneally with 104 FFU of LGTV, and mice brains were isolated
for immunohistology (n = 5). Depicted are the immunohistological analyses of the olfactory bulb of uninfected and infected mice (7 dpi). Caspase
3 (red) and DAPI (blue). Magnification ×40, scale bar 50 μm. i Quantification of Caspase 3 (Asp175+)-positive cells in the olfactory bulb of
uninfected and infected mice (7 dpi). Asterisks indicates statistical significance calculated by Mann-Whitney test, ****p < 0.0001, ***p < 0.001, **p < 0.01,
*p < 0.05. ns not significant
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of apoptosis of brain cells was observed especially in the
olfactory bulb of IPS-1−/− mice on 7 dpi while only few
apoptotic cells can be seen in the same region of WT
mice (Fig. 3h, i).
We did not observe any difference in immune cell num-
ber or composition of spleen in LGTV-infected WT and
IPS-1−/− mice (Additional file 3: Figure S3. 2A–I). In
addition, the neutralizing antibody response was also not
changed (Additional file 3: Figure S3 2J. Additional file 4:
Method S1). In overall, these data suggest that in the ab-
sence of IPS-1 signaling, LGTV replicate to higher levels in
the CNS, leading to the release of inflammatory cytokines,
which in turn results in a massive infiltration of immune
cells to the site of inflammation and apoptosis in the brain.
IPS-1 signaling is vital for restricting LGTV replication in
neurons
As described above, upon intraperitoneal infection,
LGTV is able to spread from the periphery into the
CNS. To investigate the impact of IPS-1 on viral replica-
tion and spread, we employed immunohistochemistry to
determine the anatomical location of the virus in the
brain (Fig. 4a). Viral E protein was detectable in the ol-
factory bulb and the hippocampus on 7 dpi in both WT
and IPS-1−/− mice. However, increased numbers of in-
fected cells were detected in IPS-1−/− mice. Viral E pro-
tein was mainly observed in the olfactory bulb in
neurons (Fig. 4b). However, some of the neurons in the
glomerular layer of the olfactory bulb are not terminally
differentiated to express NeuN [38], so not all LGTV-
infected cells could be identified with the NeuN marker.
Further analysis revealed an activated phenotype of the
majority of astrocytes (GFAP+) and microglia (IBA1+)
(Fig. 4b, c). The percentage of infected cells in glomeru-
lar layer of the olfactory bulb was quantified, and we
could detect a strong increase in infected neurons of
IPS-1−/− mice compared to WT. We also detected an
increased susceptibility of astrocytes and a decreased
susceptibility of microglial cell in IPS-1−/− mice (Fig. 4c).
These data indicate that mainly the neuronal cells are in-
fected by LGTV. To further define the importance of
IPS-1 signaling in neurons, primary embryonic hippo-
campal neurons were isolated and infected with LGTV
MOI 0.001, viral growth was assessed by focus forming
assay. The viral titers were higher in IPS-1 deficient neu-
rons compared to WT (Fig. 4d). These results indicate
that LGTV mainly targets neurons and that IPS-1 sig-
naling in these cells is vital for controlling viral
replication.
Local IPS-1 signaling within CNS is important for protection
against LGTV infection
The above data indicate that after peripheral infection,
virus invades the CNS and replicates more efficiently in
IPS-1−/− mice brains. However, to specifically understand
the local role of IPS-1 signaling in the protection of the
CNS against LGTV infection, we directly injected virus
intracranially in WT and IPS-1−/− mice (Fig. 5a). Al-
though both WT and IPS-1−/− mice succumbed to 100
FFU of LGTV, IPS-1−/− mice died earlier, within 7 days
compared 10 days for WT. However, a greater difference
between WT and IPS-1-/- was detected when challenged
with a low dose of LGTV (10 FFU). All WT but only
50 % of IPS-1−/− mice survived compared to the IFNAR−/−
mice that died [30]. This indicates that IPS-1 is very im-
portant for optimal antiviral response of the CNS, but
other IPS-1 independent pathways must also be involved
in the control at low viral infection doses.
Different brain regions show distinct dependency on
IPS-1 signaling for IFN-β production
Type I IFN response varies in neurons isolated from dif-
ferent brain parts [39]. To determine if IPS-1 signaling
preferentially protects a specific brain region from
LGTV infection, the brain parts were analyzed for virus
replication (Fig. 5b). WT and IPS-1−/− mice were in-
fected with LGTV intraperitoneally (104 FFU) or intra-
cranially (102 FFU), and brain regions were harvested 4
and 7 dpi for intraperitoneal and 5 dpi for intracranial
infection. Upon peripheral administration of LGTV, viral
replication was restricted to the olfactory bulb in WT
mice (Fig. 5b). High levels of viral replication was ob-
served already 4 dpi in olfactory bulb in IPS-1−/− mice
compared to the other brain regions (Additional file 5:
Figure S4), indicating that LGTV preferentially targets
the olfactory bulb. However, in the absence of IPS-1−/−,
the infection was established earlier in the brain com-
pared to WT. Upon 7 dpi LGTV spread to cerebrum
however, the RNA levels in cerebellum and brain stem
remained low. For intracranial injection, a similar trend
was observed; however, the LGTV RNA levels were
higher in IPS-1−/− in all brain regions compared to WT
(Fig. 5b).
Since IPS-1 signaling is important for the production
of type I IFN, we analyzed mRNA levels of IFN-β in the
different brain regions (Fig. 5c). Surprisingly, IFN-β
mRNA levels in the cerebrum, cerebellum, and brain
stem of IPS-1−/− mice were higher or comparable to
those of WT mice, indicating that IPS-1 plays only a
minor role in the induction of IFN-β in these brain re-
gions. In contrast, upon intraperitoneal infection, lower
mRNA level of IFN-β (p = 0.0115) was present in the ol-
factory bulb of IPS-1−/− mice compared to WT mice. Al-
though exhibiting a higher viral titer in all brain parts,
intracranially infected animals display IFN-β levels
comparable to that in WT mice, indicating that IPS-1-
mediated type I IFN production is limited to the olfac-
tory bulb.
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Fig. 4 IPS-1 is important for controlling infection in the CNS. WT and IPS-1−/− mice were infected intraperitoneally with 104 FFU of LGTV, and
mice brains were isolated for immunohistology. a Depicted are the immunohistological analyses of the glomerular layer of the olfactory bulb and
hippocampus of uninfected and infected mice (7 dpi). Representative pictures of at least two mice per group, GFAP (red), LGTV E-protein (green),
and DAPI (blue). Magnification ×10, scale bar 200 μm. b Depicted are the immunohistological analyses of the glomerular layer of the olfactory
bulb in uninfected and infected mice (7 dpi). Representative pictures of at least two mice per group, GFAP or IBA-1 or NeuN (red), LGTV E-protein
(green), and DAPI (blue). Virus-infected astrocytes, microglial cell, and neurons are indicated by a white arrow. Magnification ×40, scale bar 50 μm.
c Quantification of LGTV positive GFAP, IBA-1, and NeuN-positive cells in glomerular layer of the olfactory bulb in infected mice (7 dpi). d Primary
neurons isolated from hippocampus of WT and IPS-1−/− were infected with 0.001 MOI of LGTV; viral burden were analyzed by focus forming assay
24, 48, and 72 h post infection. Data represent the mean and standard error of the mean (SEM) of from at least three independent experiments.
Asterisks indicate statistical significance calculated by unpaired T test * p < 0.05
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Specific role of IPS-1 signaling in antiviral response in the
olfactory bulb
The data obtained thus far suggested that LGTV estab-
lishes its infection first in the olfactory bulb and the IFN-β
response induced by LGTV infection is not sufficient to
control viral replication in the absence of IPS-1. To ad-
dress the role of ISG expression during early stages of
infection, we analyzed basal expression of TBEV/LGTV-
specific antiviral ISGs [40–42] in the cerebrum and olfac-
tory bulb. Basal expression levels of viperin and IRF1 were
significantly lower in the olfactory bulb and cerebrum of
IPS-1−/− mice (Fig. 6a), while similar levels of TRIM79α
and Mx1 were present (Fig. 6a). A lower base line expres-
sion of some antiviral ISGs could increase the susceptibil-
ity of IPS-1-deficient mice, leading to higher viral
replication and higher levels of the interferon signaling an-
tagonist NS5. LGTV NS5 protein has previously been
shown to inhibit STAT1 phosphorylation and upregulation
of ISGs in vitro [43, 44]. To test this hypothesis, that high
viral replication results in low STAT1 phosphorylation,
STAT1 phosphorylation in the whole brain and different
brain regions of LGTV-infected WT and IPS-1−/− mice
was analyzed. Phospho-STAT1 was only detected 7 dpi in
IPS-1−/− whole brain even though viral replication, and
high IFN-β were detected at day 4 in such mice (Figs. 1g ,
2a, and 6b). When analyzing STAT1-P in the different
brain parts separately, a clear signal was detected 4 and
7 dpi in olfactory bulb of WT mice. A similar signal was
detected in IPS-1−/− mice only 7 dpi (Fig. 6c). These re-
sults suggest that the increased susceptibility of IPS-1−/−
mice to LGTV infection depends on a complex interplay
between many factors. First, the decreased baseline levels
of antiviral ISGs in the CNS give the virus an advantage in
IPS-1−/− mice. This is further exacerbated by the fact that
LGTV-induced IFN-β response in the olfactory bulb is
IPS-1-dependent. Finally, even though viral replication
leads to IFN-β upregulation, the increase in viral IFN sig-
naling antagonist inhibits the STAT1-P at early time
points thereby decreasing the viperin and Mx1 response
in the CNS at that point (Figs. 1g, 2a, d–e, and 6c).
Fig. 5 IPS-1 signaling controls local antiviral response within CNS. a Survival analysis of WT and IPS-1−/− mice. Mice (n = 9–10) were inoculated
with 10 or 100 FFU of LGTV via the intracranial route and monitored for mortality for 21 days. Survival differences were tested for statistical
significance by the log-rank test, * p < 0.05. b–c WT and IPS-1−/− mice were infected with LGTV intraperitoneally (104 FFU) or intracranially (102
FFU) and different regions of the brain, olfactory bulb, cerebrum, cerebellum and brain stem, were harvested 7 dpi and 5 dpi, respectively. Viral
burden (b) were quantitated by real-time qPCR detecting the 3′ NCR (detection limit 104 copies) n = 10 per experiment. IFN-β fold induction (c)
after infection was calculated by measuring IFN-β levels in uninfected and infected brain parts by real-time RT-PCR, setting the IFN-β level in
uninfected control samples to one and calculate the fold induction of IFN-β RNA transcript from infected brain parts. Asterisks indicates statistical
significance calculated by Mann-Whitney test, ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05. ns not significant, au arbitrary units
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Discussion
Protection against neurotropic LGTV infection requires
coordinated action of the type I IFN system in both per-
ipheral and CNS to prevent LGTV-induced inflamma-
tion and development of encephalitis [30]. Here, we
have characterized the function of IPS-1, a key adaptor
molecule that act downstream of RLRs (RIG-I and
MDA5) to activate the IFN and NF-κB pathways in
LGTV infection. We have shown that IPS-1 signaling is
important for controlling lethal LGTV infection. IPS-1-
deficient mice show high viral replication in the periph-
eral and CNS, increased BBB permeability, massive infil-
tration of immune cells, and uncontrolled inflammation.
After close analysis of different brain sections, we found
that IPS-1 signaling plays a role in determining the base
line levels of some antiviral ISGs but also controlling
LGTV viral replication in all brain sections. Upregula-
tion of IFN-β is specifically dependent on IPS-1 in olfac-
tory bulb. Thus, we propose a specific role of pattern
recognition receptors in the different sections of the
brain in neurotropic LGTV infection.
Neuroinvasiveness and neurovirulence are key steps in
the pathogenesis of neurotropic viruses. The type I IFN
system is an important component of innate immunity
and limits viral load of many flavivirus infections [4].
Previously, we showed that IFNAR−/− mice succumb to
LGTV infection within 5 days with uncontrolled sys-
temic viremia [30]. LGTV-infected IPS-1−/− mice
showed declined systemic type I IFN responses. This
finding agrees with our previous studies indicating that
recognition of LGTV is IPS-1-dependent [31] and that
induction of type I IFN production by other RNA viruses
is mediated by IPS-1-dependent mechanisms [45–47].
The lower systemic IFN response probably contributed
to higher systemic viral levels, thus contributing to
higher viral titers and earlier time point of neuroinva-
siveness (Additional file 5: Figure S4 ). However, no dif-
ference in neutralizing antibody titers or spleen immune
cell composition was detected. These later findings are
markedly different compared to the effect seen in WNV
infected IPS-1−/− mice [47]. Virus entry into the brain by
LGTV, TBEV, and Japanese encephalitis is independent
of the integrity of the BBB because virus is detectable
even when the BBB is intact [30, 48, 49], and this is also
true in IPS-1 deficient-mice.
The brain has distinct immune responses to pathogens
and injury where resident brain cells including microglia
and astrocytes, which are unique innate immune cells
without direct counterparts in the periphery, can pro-
duce IFN and proinflammatory cytokines and can cross-
talk with infiltrating immune cells [50–53]. Local type I
IFN response is very important for controlling lethal
LGTV infection in the CNS [30]. Indeed, high levels of
LGTV replication were detected in the brain of IPS-1-
deficient mice compared to WT. This in turn could lead
to elevated IFN-β response in the brains due to in-
creased activation of IPS-1-independent pathways. How-
ever, increased IFN response neither led to the induction
of antiviral effector genes early in infection nor was it
able to control the viral infection. One explanation
Fig. 6 IPS-1−/− mice show lower basal expression of antiviral ISGs and a delayed STAT1 phosphorylation in the olfactory bulb after LGTV infection.
a Basal expression level of viperin, TRIM79α, Mx1, and IRF1 were determined by real-time RT-PCR for the olfactory bulb and cerebrum of uninfected WT
and IPS-1-/- mice. The data is displayed as relative expression levels values compared to the basal level of GAPDH. Data represent the mean and standard
error of the mean (SEM) of five mice. Asterisks indicates statistical significance calculated by Mann-Whitney test, *p< 0.05. WT and IPS-1−/− mice were
infected with LGTV intraperitoneally (104 FFU), and whole brain (b) and olfactory bulb (c) were dissected out 0, 4, and 7 dpi and protein analysis of the
STAT1-P, STAT1, and actin was measured by Western blot. Representative pictures are shown (n= 2)
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might be that LGTV and TBEV non-structural protein
NS5 can inhibit JAK STAT pathway downstream of
IFNAR to block effector functions of IFN, e.g., upregula-
tion of ISGs [43, 44]. Accordingly, in spite of the pres-
ence of high levels of viral RNA and IFN-β in brains of
IPS-1−/− mice, day 4 post infection, STAT1 phosphoryl-
ation was not detectable and neither was ISG expression.
Other studies have shown that even in the presence of
type I IFN, viral replication could not be controlled and
that other mechanisms like IRF-1 are essential to control
viral replication [34]. IPS-1 located on peroxisomes has
been shown to induce an IRF-1-dependent IFN-
independent antiviral mechanism [54], which has been
shown to be important for both VSV and HCV [34, 55].
This pathway might be one of the reasons why IPS-1-
deficient mice cannot control the LGTV infection in
CNS.
Higher viral burden observed in IPS-1−/− mice brains
was a result of higher viral replication in neurons, simi-
lar to LGTV-infected TLR7−/− mice brains [56]. Al-
though not highly infected, astrocytes and microglia
showed an activated phenotype as evident from in-
creased expression of GFAP and IBA-1, respectively. As-
trocytes are the most abundant glial cell population in
the brain and when activated could act as potential
source of proinflammatory cytokines. These cytokines
might contribute to BBB breakdown and TBEV induced
neurotoxicity and thus play a major role in TBEV patho-
genesis [57, 58]. We also detected a strong inflammatory
response in the IPS-1−/− mice leading to the opening of
BBB and activation of the cell-mediated immune re-
sponse with high quantity of infiltrating CD4 and CD8 T
cells in later stages of infection. Although a strong T cell
response was observed, it was not protective; similar
findings were also seen in case of WNV [47]. Notably ra-
ther than protection, this higher T cell response in the
brain contributed to immunopathology [59]. Apoptosis
in the brains of LGTV-infected IPS-1−/− mice were ap-
parent as a result of high viral infection and inflamma-
tory response, which combined ultimately lead to the
death of mice.
Local immune response within the CNS plays an im-
portant role in combating viral infections [60]. In the ab-
sence of IFNAR signaling in the CNS, LGTV replicated
to higher levels and mice succumbed early to the infec-
tion [30]. Studies with Sindbis, JEV, and WNV reports
that the IPS-1 pathway is important in controlling viral
replication in the brain [47, 61, 62]. Comparison of the
different brain regions displays specific antiviral mecha-
nisms [39, 63, 64]. Two neuronal subtypes, granule cell
neurons of the cerebellum and cortical neurons from the
cerebral cortex, have unique innate immune programs
and showed differential permissiveness to replication of
several positive-stranded RNA viruses [39]. Cerebellum
has also been shown to be more resistant to WNV viral
infection compared to cerebrum [39], and this holds true
for LGTV as well. One explanation for this might be an
increased basal expression of ISGs such as Ifi27, Irg1,
viperin, and Stat1 in granule neurons [39]. IPS-1 signal-
ing seems to be very important to restrict LGTV growth
throughout the brain. Although, high IFN-β levels were
detected in IPS-1−/−, it could not restrict replication in
any of the brain regions. Comparison of the basal ex-
pression levels of some ISGs known to be active against
TBEV, LGTV, or flaviviruses in general [41, 42, 65, 66]
revealed that the olfactory bulb generally shows higher
levels of viperin, TRIM79α, Mx1, and IRF1 compared to
cerebrum. This might play a role for defense against
pathogens which enter the brain preferentially via the ol-
factory route. IPS-1-deficient mice have lower expression
of some specific ISG but not all. Since TBEV and LGTV
are very sensitive to the antiviral action of viperin [42]
(unpublished data), this might be one of the contributing
reasons why IPS-1-deficient mice are more susceptible
to LGTV infection. This initial advantage might also
contribute to higher levels of viral NS5 and inhibition of
STAT1 phosphorylation in IPS-1 deficient mice. This is
in contrast to wild-type mice that have higher basal
levels of antiviral ISGs, respond faster by production of
IFN-β, and have a more robust STAT1-mediated expres-
sion of ISGs required to contain the infection. Notably,
LGTV infection was restricted to olfactory bulb in WT
mice. Similar observations were made in VSV and cyto-
megalovirus (CMV) infections. VSV- and CMV-induced
long-distance interferon signaling within the brain that
blocks virus spread [67] and astrocytes were found to be
the main producer of IFN-β in the olfactory bulb in re-
sponse to VSV infection [18]. In LGTV infection, the ol-
factory bulb seems to be more dependent on IPS-1
signaling for IFN-β production compared to the other
brain parts, where RLR independent pathways (MyD88
and TRIF) compensated with higher IFN-β production.
Thus, different cell types might exert specific immune
response in different sections of the brain.
Conclusions
In summary, IPS-1 signaling is important to coordinate
and shape the innate immune response within the per-
ipheral and CNS during LGTV infection. In our study,
we show that some antiviral ISGs have lower basal
expression levels in IPS-1 deficient mice, which may
contribute to a higher viral burden. We also show that
IPS-1 signaling is more important for IFN-β production
in olfactory bulb compared to the other brain regions.
We propose that various PRR pathways regulate the IFN
response within different sections of the brain. To this
end, further studies are underway to determine what cell
types and antiviral factors govern the differential role of
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PRRs in the different regions of the brain during LGTV
and TBEV infections. This study will contribute to the
understanding of regional immunological diversity
within the CNS and its impact on neurotropic virus
infections.
Additional files
Additional file 1: Figure S1. IPS-1−/− mice have lower IFN-α levels in
serum after LGTV infection compared to WT mice. WT and IPS-1−/− mice
were infected intraperitoneally with 104 FFU of LGTV, and serum samples
were collected at indicated time points (n = 5–10). The amount of IFN-α
in the mouse serum was determined by enzyme linked immunosorbent
assay (ELISA) according to the manufacturer’s instructions (PBL). Significance
was calculated with student’s T test, *p < 0.05. (PDF 53.6 KB)
Additional file 2: Figure S2. Effect of IPS-1 signaling on BBB permeability
upon LGTV infection. WT and IPS-1−/− mice were mock or intraperitoneally
infected with 104 FFU of LGTV (n = 3). Mice were intravenously injected with
100 μl 2 % Evans blue (Sigma) in PBS 4 and 7 dpi. After 1 h, animals were
transcardially perfused with 20 ml PBS and the brains were removed. The
brains were weighted and homogenized in 50 % TCA, and absorbance was
measured at 610 nm. The absorbance was divided by the weight of the
sample and normalized to mock infected samples. (PDF 42.5 KB)
Additional file 3: Figure S3. IPS-1 does not influence the humoral
response or cell composition or number in the spleen. WT and IPS-1−/−
mice were infected intraperitoneally with 104 FFU of LGTV. Spleens were
harvested 4 and 7 dpi, and immune cells were isolated, counted, stained
for various cell markers and analyzed by flow cytometry (n = 5–10). (A)
Absolute cell numbers. (B) Total CD4+ T cells. (C) Total CD8+ cells. (D)
Total B220+ cells. (E) Total CD11b+ cells. (F) Total CD11c+ cells. (G) Total
NKT cells. (H) Total NK cells. (I) Total regulatory T (Treg) cells. (J) WT and
IPS-1−/− mice were mock or intraperitoneally infected with 104 FFU of
LGTV, and the serum was isolated on 0, 4, and 7 dpi. Neutralizing
antibody titers were determined by virus neutralization assay. Data
represents mean with SEM of 5–10 mice in each group per time point.
(PDF 20.6 KB)
Additional file 4: Method S1. Virus neutralization assay. Neutralization
titer of antibody solution was determined by modified method of plaque
reduction neutralization test (PRNT) called as rapid fluorescent focus
inhibition test (RFFIT) [68, 69]. Briefly, mice sera were diluted 1:10 in
serum-free maintenance media and heat-inactivated. The sera were
serially diluted and incubated with 50 FFU LGTV for 1 h, and focus
forming assay was performed. Neutralizing antibody titer was calculated
as the reciprocal of serum dilution that gave 50 % (NT50) reduction of the
number of FFU as compared to virus control. The test was accepted if
virus dose was in the range of 30–90 FFU. (DOC 21.5 KB)
Additional file 5: Figure S4. Enhanced viral replication in olfactory
bulb of IPS-1−/− mice 4 dpi. WT and IPS-1 deficient mice were infected
intraperitoneal with LGTV and olfactory bulb, cerebrum, cerebellum and
brain stem was collected 4 dpi. LGTV RNA levels were quantified with the
NS3 real-time qPCR assay (detection limit 10 copies). Asterisks indicates
statistical significance between IPS-1−/− olfactory bulb compared to
other brain regions and calculated by Mann-Whitney test. Number sign
indicates not detectable. (PDF 45.6 KB)
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